Dihydropyridine calcium channel blockers and peripheral side effects

Journal of Human Hypertension

Volumn 15, Issue 10, 2001, Pages 745-746

  Sirker, A ^a   Missouris, C G ^a   MacGregor, G A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Calcium channel blockers; Dihydropyridine

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; NIFEDIPINE;

ADULT; ANAMNESIS; ANKLE EDEMA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE REPORT; CAUCASIAN; CLINICAL EXAMINATION; DRUG WITHDRAWAL; ERYTHEMA; HUMAN; HYPERPIGMENTATION; HYPERTENSION; LEG; MALE; PETECHIA; RASH; TABLET;

CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; EDEMA; ERYTHEMA; EXANTHEMA; HUMANS; HYPERPIGMENTATION; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE;

EID: 0034757254     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001248     Document Type: Article

References (8)

1. Nifedipine and therapy in angina pectoris: Evaluation of safety and side-effects
2. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension: Results of a multicentre trial
3. Nifedipine gastrointestinal therapeutic system for hypertensive patients in a primary care setting: Results of Extended Release Adalat Canadian Trial (EXACT)
4. The safety of amlodipine
5. Vasodilation-related adverse events in diltiazem and dihydropyridine calcium antagonists studied by prescription-event monitoring
6. Impaired venoarteriolar reflex as a possible cause for nifedipine-induced ankle oedema
7. Fluid retention with nifedipine in antihypertensive therapy
8. Selected side-effects: 1. Peripheral oedema with dihyfropyridine calcium antagonists